Literature DB >> 33334284

Metabolism and Pharmacological Mechanisms of Active Ingredients in Erigeron breviscapus.

Fan Hua1, Lin Peng1, Kang Qiang1, Zhao Zhi-Long1, Wang Ji1, Cheng Jia-Yi2.   

Abstract

BACKGROUND: Erigeron breviscapus (Vant.) Hand-Mazz. is a plant species in the Compositae family. More than 10 types of compounds-such as flavonoids, caffeinate esters, and volatile oils-have been identified in Erigeron breviscapus; however, it remains unknown as to which compounds are associated with its clinical efficacy. In recent years, flavonoids and phenolic acids have been considered as the main effective components of Erigeron breviscapus. The metabolism and mechanisms of these compounds in vivo have been extensively studied to improve our understanding of the drug.
METHODS: In the present review, we summarize the relationships among these compounds, their metabolites, and their pharmacodynamics. Many methods have been implemented to improve the separation and bioavailability of these compounds from Erigeron breviscapus.
RESULTS: In China, Erigeron breviscapus has been used for many years. In recent years, through the study of its metabolism and the mechanisms of its effective components, the effects of Erigeron breviscapus in the treatment of various diseases have been extensively studied. Findings have indicated that Erigeron breviscapus improves cardiovascular and cerebrovascular function, and that one of its ingredients, scutellarin, has potential value in the treatment of Alzheimer's disease, cancer, diabetic vascular complications, and other conditions. In addition, phenolic acid compounds and their metabolites also play an important role in anti-oxidation, anti-inflammation, and improving blood lipids.
CONCLUSION: Erigeron breviscapus plays an important role in the prevention and treatment of cardiovascular/cerebrovascular diseases, neuroprotection, and cancer through many different mechanisms of action. Further investigation of its efficacious components and metabolites may provide more possibilities for the clinical application of traditional Chinese medicine and the development of novel drugs. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Erigeron breviscapus; flavonoids; metabolism; pharmacological mechanism; phenolic acids; scutellarin

Year:  2020        PMID: 33334284     DOI: 10.2174/1389200221666201217093255

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  3 in total

Review 1.  Erigeron breviscapus (Vant.) Hand-Mazz.: A Promising Natural Neuroprotective Agent for Alzheimer's Disease.

Authors:  Xiaoyu Dong; Shengtao Qu
Journal:  Front Pharmacol       Date:  2022-04-26       Impact factor: 5.988

Review 2.  Chinese Medical Injections for Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Network Meta-analysis.

Authors:  Haiyin Hu; Zhaochen Ji; Xiaoyu Qiang; Shigang Liu; Xiaodi Sheng; Zhe Chen; Fanqi Liu; Hui Wang; Junhua Zhang
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2021-12-17

Review 3.  Treatment of Glaucoma with Natural Products and Their Mechanism of Action: An Update.

Authors:  Ru Hui Sim; Srinivasa Rao Sirasanagandla; Srijit Das; Seong Lin Teoh
Journal:  Nutrients       Date:  2022-01-26       Impact factor: 5.717

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.